Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-01-18

Clinical Trial Update: Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines whether discontinuing aspirin after head trauma lowers the incidence of chronic subdural hematoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Head Trauma, Traumatic Brain Injury | Phase 4 | Status: UNKNOWN